Loading...
•
Dec 31, 2024
Select Medical Q4 2024 Earnings Report
Select Medical reported revenue growth in Q4 2024 but faced a loss from continuing operations due to one-time charges.
Key Takeaways
Select Medical Holdings Corporation reported a 7.8% increase in revenue for Q4 2024, reaching $1.31 billion. However, the company posted a net loss from continuing operations of $10.5 million due to a one-time stock compensation acceleration of $45.9 million and a $17.9 million loss on early retirement of debt. Adjusted EPS increased by 50% to $0.18. Adjusted EBITDA rose 3.8% to $116.0 million.
Q4 revenue grew 7.8% YoY to $1.31 billion.
Loss from continuing operations was $10.5 million due to one-time expenses.
Adjusted EPS increased 50% YoY to $0.18.
Adjusted EBITDA rose 3.8% to $116.0 million.
Select Medical
Select Medical
Select Medical Revenue by Segment
Revenue by Segment
Critical Illness Recovery Hospital Revenue
CapyFin.comRehabilitation Hospital Revenue
CapyFin.comOutpatient Rehabilitation Revenue
CapyFin.com Forward Guidance
For 2025, Select Medical expects revenue between $5.4 billion and $5.6 billion, Adjusted EBITDA between $520 million and $540 million, and diluted EPS between $1.09 and $1.19.
Positive Outlook
- Revenue expected to grow to $5.4B - $5.6B in 2025.
- Adjusted EBITDA projected between $520M - $540M.
- EPS expected to rise between $1.09 - $1.19.
- Improved cost control measures expected to enhance margins.
- Expansion in rehabilitation and outpatient services planned.
Challenges Ahead
- Continued impact of labor cost inflation on margins.
- Higher interest expenses due to recent debt refinancing.
- Potential reimbursement pressures from government programs.
- Challenges in retaining and attracting qualified healthcare professionals.
- Macroeconomic uncertainties affecting patient volumes.